Document Detail


Effect of intensive versus standard blood pressure control on depression and health-related quality of life in type 2 diabetes: the ACCORD trial.
MedLine Citation:
PMID:  22584134     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVE: We tested the hypothesis that intensive (systolic blood pressure [SBP] <120 mmHg) rather than standard (SBP 130-139 mmHg) blood pressure (BP) control improves health-related quality of life (HRQL) in those with type 2 diabetes.
RESEARCH DESIGN AND METHODS: Subjects were 1,028 ACCORD (Action to Control Cardiovascular Risk in Diabetes) BP trial HRQL substudy participants who completed baseline and one or more 12-, 36-, or 48-month HRQL evaluations. Multivariable linear regression assessed impact of BP treatment assignment on change in HRQL.
RESULTS: Over 4.0 years of follow-up, no significant differences occurred in five of six HRQL measures. Those assigned to intensive (vs. standard) BP control had statistically significant worsening of the Medical Outcomes Study 36-item short-form health survey (SF36) physical component scores (-0.8 vs. -0.2; P = 0.02), but magnitude of change was not clinically significant. Findings persisted across all prespecified subgroups.
CONCLUSIONS: Intensive BP control in the ACCORD trial did not have a clinically significant impact, either positive or negative, on depression or patient-reported HRQL.
Authors:
Patrick J O'Connor; K M Venkat Narayan; Roger Anderson; Patricia Feeney; Larry Fine; Mohammed K Ali; Debra L Simmons; Don G Hire; JoAnn M Sperl-Hillen; Lois Anne Katz; Karen L Margolis; Mark D Sullivan
Related Documents :
9048274 - Temporal variation in the effects of ophthalmic timolol on cardiovascular and respirato...
8295364 - Ocular hypotensive effect of phxa41 in patients with ocular hypertension or primary ope...
17914204 - Comparing dynamic contour tonometry to goldmann and hand-held tonometry in normal, ocul...
3561934 - Vitreoretinal changes associated with rise in intraocular pressure after nd:yag capsulo...
6727724 - An on-line method for evaluation of the in vitro pulsatile pressure drop and regurgitat...
9039584 - Gadopentetate dimeglumine and iodinated contrast media. hemodynamic side effects after ...
Publication Detail:
Type:  Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural     Date:  2012-05-14
Journal Detail:
Title:  Diabetes care     Volume:  35     ISSN:  1935-5548     ISO Abbreviation:  Diabetes Care     Publication Date:  2012 Jul 
Date Detail:
Created Date:  2012-06-22     Completed Date:  2012-10-23     Revised Date:  2013-04-16    
Medline Journal Info:
Nlm Unique ID:  7805975     Medline TA:  Diabetes Care     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1479-81     Citation Subset:  IM    
Affiliation:
HealthPartners Research Foundation, Minneapolis, MN, USA. patrick.j.oconnor@healthpartners.com
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Blood Pressure / drug effects*
Depression
Diabetes Mellitus, Type 2 / blood,  drug therapy,  psychology*
Humans
Hypertension / drug therapy*
Quality of Life
Grant Support
ID/Acronym/Agency:
N01-HC-095183/HC/NHLBI NIH HHS

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Analysis of glucose responses to automated insulin suspension with sensor-augmented pump therapy.
Next Document:  Severe hypoglycemia and cardiovascular disease incidence in type 1 diabetes: the EURODIAB Prospectiv...